PI
JAZZ icon

Placemark Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Placemark Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$679K Buy
4,151
+429
+12% +$71.2K 0.01% 1049
2014
Q3 		$598K Buy
3,722
+732
+24% +$113K 0.01% 1110
2014
Q2 		$438K Buy
2,990
+488
+20% +$67.7K 0.01% 1224
2014
Q1 		$346K Sell
2,502
-898
-26% -$135K 0.01% 1280
2013
Q4 		$428K Sell
3,400
-3,165
-48% -$328K 0.01% 1206
2013
Q3 		$604K Buy
6,565
+236
+4% +$19K 0.01% 1013
2013
Q2 		$434K Buy
+6,329
New +$387K 0.01% 1103

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Placemark Investments's JAZZ Position: Q4 2014 in Review

Placemark Investments increased its Jazz Pharmaceuticals (JAZZ) stake by 12% in Q4 2014, buying an estimated $71.2K and bringing the position to 4,151 shares worth $679K. The position accounts for 0.01% of the portfolio, ranked #1049.

Placemark Investments first reported a position in JAZZ in Q2 2013 and has held it in 7 quarters since. 357 funds tracked by Wall St. Rank hold JAZZ as of Q4 2014.

  • Placemark Investments held 4,151 shares of Jazz Pharmaceuticals worth $679K as of Q4 2014.
  • Placemark Investments bought 429 Jazz Pharmaceuticals shares in Q4 2014, an estimated $71.2K.
  • Jazz Pharmaceuticals made up 0.01% of Placemark Investments's portfolio in Q4 2014, its #1049 holding.
  • Placemark Investments first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 7 quarters since.
  • 357 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2014.

Based on Placemark Investments's 13F filing for Q4 2014, filed 17 Feb 2015.